Zuo, Yu <br/><br/>
17‑AAG synergizes with Belinostat to exhibit a negative effect on the proliferation and invasion of MDA‑MB‑231 breast cancer cells.  [electronic resource] 

 -  Oncology reports  06 2020 
 - 1928-1944 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1791-2431 
<br/><br/><label>Standard No.: </label>10.3892/or.2020.7563  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Benzoquinones--pharmacology<br/>Cell Movement--drug effects<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Drug Synergism<br/>Female<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Regulatory Networks--drug effects<br/>Humans<br/>Hydroxamic Acids--pharmacology<br/>Lactams, Macrocyclic--pharmacology<br/>MCF-7 Cells<br/>Reactive Oxygen Species--metabolism<br/>Sequence Analysis, RNA<br/>Sulfonamides--pharmacology<br/>Triple Negative Breast Neoplasms--drug therapy